Guardian Pharmacy Services, Inc.
For the period ended Dec 31, 2024. Filed Mar 26, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 26, 2025
GRDN$49.85+6.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 15. Exhibits and Financial Statement Schedules
| Item 15. | Exhibits and Financial Statement Schedules. |
|---|
(a)(1) Financial Statements:
See Part II, Item 8. For the index to financial statements.
(a)(2) Financial Statement Schedules:
All financial statements schedules have been omitted because they are not applicable, not required or the information required is shown in the financial statements or the notes thereto.
(a)(3) Exhibits:
| Incorporated by Reference | |||||
|---|---|---|---|---|---|
| Exhibit Number | Description | Form | File Number | Exhibit | Filing Date |
| 2.1 | Agreement and Plan of Merger, dated as of September 27, 2024, by and among Guardian Merger Corp., Guardian Pharmacy, LLC and Guardian Pharmacy Services, Inc. | 8-K | 001-42284 | 2.1 | 09/30/2024 |
| 3.1 | Amended and Restated Certificate of Incorporation of the Registrant. | 8-K | 001-42284 | 3.1 | 09/30/2024 |
| 3.2 | Amended and Restated Bylaws of the Registrant. | 8-K | 001-42284 | 3.2 | 09/30/2024 |
| 4.1 | Stockholders’ Agreement, dated as of September 25, 2024, by and among Guardian Pharmacy Services, Inc., Bindley Capital Partners I, LLC, Pharmacy Investors, LLC, Cardinal Equity Fund LP, Fred Burke, David Morris and Kendall Forbes. | 8-K | 001-42284 | 4.1 | 09/30/2024 |
| 4.2 | Description of Registrant’s Securities. | ||||
| 10.1+ | Guardian Pharmacy Services, Inc. 2024 Equity and Incentive Compensation Plan. | S-1/A | 333-274847 | 10.5 | 09/16/2024 |
| 10.2+ | Employment Agreement by and between Guardian Pharmacy Services Management, LLC and Fred Burke. | 8-K | 001-42284 | 10.2 | 09/30/2024 |
| 10.3+ | Employment Agreement by and between Guardian Pharmacy Services Management, LLC and David Morris. | 8-K | 001-42284 | 10.3 | 09/30/2024 |
| 10.4+ | Employment Agreement by and between Guardian Pharmacy Services Management, LLC and Kendall Forbes. | 8-K | 001-42284 | 10.4 | 09/30/2024 |
| 10.5+ | Form of Restricted Stock Unit Notice of Grant and Award Agreement (Directors) under the Guardian Pharmacy Services, Inc. 2024 Equity and Incentive Compensation Plan. | 10-Q | 001-42284 | 10.5 | 11/12/2024 |
| Incorporated by Reference | |||||
|---|---|---|---|---|---|
| Exhibit Number | Description | Form | File Number | Exhibit | Filing Date |
| 10.6 | Third Amended and Restated Loan and Security Agreement, dated as of April 23, 2018, by and among Guardian Pharmacy, LLC, the subsidiary guarantors from time to time party thereto, Regions Bank as administrative agent and collateral agent, and the lenders from time to time party thereto. | S-1/A | 333-274847 | 10.4(a) | 09/16/2024 |
| 10.7 | First Amendment to Third Amended and Restated Loan and Security Agreement, dated as of December 3, 2019, by and among Guardian Pharmacy, LLC, the guarantors party thereto, the lenders party thereto, and Regions Bank as administrative agent and collateral agent. | S-1/A | 333-274847 | 10.4(b) | 09/16/2024 |
| 10.8 | Second Amendment to Third Amended and Restated Loan and Security Agreement, dated as of March 20, 2020, by and among Guardian Pharmacy, LLC, the guarantors party thereto, the lenders party thereto, and Regions Bank as administrative agent and collateral agent. | S-1/A | 333-274847 | 10.4(c) | 09/16/2024 |
| 10.9 | Third Amendment to Third Amended and Restated Loan and Security Agreement, dated as of December 22, 2021, by and among Guardian Pharmacy, LLC, the guarantors party thereto, the lenders party thereto, and Regions Bank as administrative agent and collateral agent. | S-1/A | 333-274847 | 10.4(d) | 09/16/2024 |
| 10.10 | Fourth Amendment to Third Amended and Restated Loan and Security Agreement, dated as of April 22, 2022, by and among Guardian Pharmacy, LLC, the guarantors party thereto, the lenders party thereto, and Regions Bank as administrative agent and collateral agent. | S-1/A | 333-274847 | 10.4(e) | 09/16/2024 |
| 10.11 | Fifth Amendment to Third Amended and Restated Loan and Security Agreement, dated as of October 13, 2023, by and among Guardian Pharmacy, LLC, the guarantors party thereto, the lenders party thereto, and Regions Bank as administrative agent and collateral agent. | S-1/A | 333-274847 | 10.4(f) | 09/16/2024 |
| 10.12 | Sixth Amendment to Third Amended and Restated Loan and Security Agreement, dated as of May 13, 2024, by and among Guardian Pharmacy, LLC, the guarantors party thereto, the lenders party thereto, and Regions Bank as administrative agent and collateral agent. | S-1/A | 333-274847 | 10.4(g) | 09/16/2024 |
| 10.13 | Borrower Assignment, Assumption and Joinder Agreement, dated as of December 20, 2024, by and among Guardian Pharmacy, LLC, as assignor, Guardian Pharmacy Services, Inc., as assignee, the guarantors party thereto and Regions Bank, as Agent. | 8-K | 001-42284 | 10.1 | 12/20/2024 |
| Incorporated by Reference | |||||
| Exhibit Number | Description | Form | File Number | Exhibit | Filing Date |
| 10.14 | Seventh Amendment to Third Amended and Restated Loan and Security Agreement, dated as of December 20, 2024, by and among Guardian Pharmacy Services, Inc., the guarantors party thereto, the lenders party thereto, and Regions Bank as administrative agent and collateral agent. | ||||
| 19.1 | Insider Trading Policy. | ||||
| 21.1 | List of Subsidiaries of Guardian Pharmacy Services, Inc. | ||||
| 23.1 | Consent of Ernst & Young LLP. | ||||
| 31.1 | Certification of the Principal Executive Officer Pursuant to Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||||
| 31.2 | Certification of the Principal Financial and Accounting Officer Pursuant to Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||||
| 32.1 | Certification of the Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||||
| 32.2 | Certification of the Principal Financial and Accounting Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||||
| 97.1 | Compensation Recoupment Policy. | ||||
| 101.INS | XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | ||||
| 101.SCH | XBRL Taxonomy Schema Linkbase Document | ||||
| 101.CAL | XBRL Taxonomy Calculation Linkbase Document | ||||
| 101.DEF | XBRL Taxonomy Definition Linkbase Document | ||||
| 101.LAB | XBRL Taxonomy Label Linkbase Document | ||||
| 101.PRE | XBRL Taxonomy Presentation Linkbase Document | ||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). | ||||
| + | Indicates management contract or compensatory plan. |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.